Semaglutide ameliorates diabetes-associated cognitive dysfunction in mouse model of type 2 diabetes

QR Code

Semaglutide ameliorates diabetes-associated cognitive dysfunction in mouse model of type 2 diabetes

Saved in:

Bibliographic Details
Main Authors:	Yan Zhu, Yi He, Hongyan Yang, Yanbo Gao, Yan Wang, Peiqing Liu, Mengjuan Zhang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12225814/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness of semaglutide on survival outcomes in patients with type 2 diabetes and chronic kidney disease
by: Takao Kato, et al.
Published: (2025-07-01)

Ameliorative Effect of Parabacteroides distaxsonis on Cognitive Impairment Caused by Type 2 Diabetes Mellitus
by: DU Yue, ZHAO Zhongna, LIU Xuebo
Published: (2025-05-01)

Association of semaglutide use with depressive symptoms and suicidal behavior in a patient with type 2 diabetes: A case report
by: Anisija Stojkovska, et al.
Published: (2025-07-01)

Association of Different Types of Diabetic Autonomic Neuropathy With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes: A Cross‐Sectional Study
by: Ruixue Feng, et al.
Published: (2025-07-01)

Multi-omics characterization of diabetic nephropathy in the db/db mouse model of type 2 diabetes
by: Liping Wang, et al.
Published: (2025-01-01)

ROLE OF NEUROSPECIFIC PROTEINS IN THE DEVELOPMENT OF COGNITIVE DYSFUNCTION IN PATIENTS WITH TYPE 1 DIABETES
by: M. V. Novosyolova, et al.
Published: (2014-04-01)

The Role of Insulin Deficiency in Cognitive Dysfunction in Patients with Type 1 Diabetes Mellitus
by: Yu. V. Bykov
Published: (2024-06-01)

Semaglutide Therapy and Accelerated Sarcopenia in Older Adults with Type 2 Diabetes: A 24-Month Retrospective Cohort Study
by: Ren Q, et al.
Published: (2025-07-01)

Recombinant Irisin Ameliorates Insulin Resistance in Type 2 Diabetic Mice
by: Sana Akram, et al.
Published: (2025-03-01)

The results of correction of endothelial dysfunction in type 2 diabetes mellitus in patients with diabetic retinopathy and associated hypertension
by: L. K. Moshetova, et al.
Published: (2014-07-01)

Prevalence and pattern of cognitive dysfunction in young adults and middle-aged patients with type-2 diabetes
by: Subhankar Chatterjee, et al.
Published: (2025-06-01)

Role of endothelial dysfunction in the pathogenesis of diabetic retinopathy in patients with type 2 diabetes
by: I. V. Vorobyeva, et al.
Published: (2014-07-01)

Alpha-Lipoic Acid and Metformin Combination Therapy Synergistically Activate Nrf2-AMPK Signaling Pathways to Ameliorate Cognitive Dysfunction in Type 2 Diabetic Encephalopathy: A Preclinical Study
by: Abdulmajeed F. Alrefaei, et al.
Published: (2025-07-01)

Use of Congenic Mouse Strains for Gene Identification in Type 1 Diabetes
by: Rogner, Ute Christine
Published: (2011)

Obtaining a mouse model of streptozotocininduced type 1 diabetes mellitus
by: G. N. Skaletskaya, et al.
Published: (2024-07-01)

Cognitive impairments in type 1 diabetes mellitus
by: Yu. V. Bykov, et al.
Published: (2023-02-01)

Type 2 Diabetes Mellitus and Cognitive Impairment
by: Johanda Damanik, et al.
Published: (2021-07-01)

Real-World HbA1c Changes Among Type 2 Diabetes Mellitus Patients Initiating Treatment With a 1.0 Mg Weekly Dose of Semaglutide for Diabetes
by: Noelle N. Gronroos, et al.
Published: (2024-11-01)

Endothelial Dysfunction and Therapeutic Intervention in Type 2 Diabetes
by: Páez, Fernando Grover
Published: (2011)

Thyroid Dysfunction in Patients with Type 2 Diabetes Mellitus
by: Annia Quintana Marrero, et al.
Published: (2020-09-01)

Formyl peptide receptor 2 antagonist WRW4 ameliorates diabetes-induced cognitive decline in mice
by: Hiroki Uno, et al.
Published: (2025-09-01)

Semaglutide therapy and iatrogenic thyrotoxicosis
by: Maxim John Levy Barnett, et al.
Published: (2025-07-01)

PREDICTORS OF PERSISTANT POST-OPERATION COGNITIVE DYSFUNCTION IN 2 TYPE DIABETES PATIENTS AFTER CORONARY BYPASS GRAFTING
by: О. A. Trubnikova, et al.
Published: (2016-02-01)

Weight Loss Effects of Once-Weekly Semaglutide 2.4 mg in Adults with and Without Type 2 Diabetes: A Systematic Review and Meta-Analysis
by: Boram Hong, et al.
Published: (2025-07-01)

TREATMENT OF NEUROGENIC ERECTILE DYSFUNCTION IN PATIENTS WITH TYPE I DIABETES
by: D. G. Kurbatov, et al.
Published: (2017-03-01)

Corylin ameliorates inflammaging and pyroptosis in diabetic periodontitis: A preliminary in vitro study
by: Taichen Lin, et al.
Published: (2025-07-01)

Granuloma annulare after starting semaglutide
by: Tajena Jones, BS, et al.
Published: (2025-08-01)

A review of type 2 diabetes mellitus and cognitive impairment
by: Wen Kan, et al.
Published: (2025-08-01)

Influence of Aging and Diabetes on the Mechanical Properties of Mouse Skin
by: Sarah Miny, et al.
Published: (2025-06-01)

ERECTILE DYSFUNCTION IN PATIENTS WITH TYPE 1 DIABETES: DIAGNOSIS AND TREATMENT METHODS
by: D. G. Kurbatov, et al.
Published: (2014-06-01)

Assessment of Thyroid Dysfunction and Thyroid Auto-Antibodies in Type 1 Diabetes
by: Hajieh BiBi Shahbazian, et al.
Published: (2012-03-01)

Safety considerations of semaglutide in the potential treatment of Alzheimer's disease: A pooled analysis of semaglutide in adults aged ≥ 65 years
by: Marwan Sabbagh, et al.
Published: (2025-04-01)

Associations Between Renal Dysfunction Subtypes and Vertebral Fracture in Patients with Type 2 Diabetes: A Longitudinal Study
by: Hu N, et al.
Published: (2025-06-01)

ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CORONARY HEART DISEASE AND TYPE 2 DIABETES MELLITUS
by: M. M. Petina, et al.
Published: (2011-04-01)

Nonlinear Association Between Serum 25‐Hydroxyvitamin D and Cardiac Autonomic Dysfunction in Diabetic Foot: A Threshold Effect on Heart Rate Variability
by: Mingxin Bai, et al.
Published: (2025-06-01)

Treatment with pemafibrate ameliorates fatty liver index and atherogenic lipid profiles in Japanese patients with type 2 diabetes mellitus
by: Toru Suzuki, et al.
Published: (2025-07-01)

A Global Misuse of Semaglutide for Cosmetic Weight Loss in Non-diabetic Young Population, an FDA Public Database and Google Trends Data Analysis
by: Nahid Sabah aldin Saber, et al.
Published: (2025-08-01)

Long-Term Effect of Semaglutide on the Glomerular Filtration Rate Slope in High-Risk Patients with Diabetic Nephropathy: Analysis in Real-World Clinical Practice
by: Enrique Luna, et al.
Published: (2025-07-01)

Mogrosides Protect Against Diabetic Kidney Injury via Inhibiting Macrophage Activation in a Mouse Model
by: Fangyi Jiang, et al.
Published: (2025-01-01)

DIABETIC RETINOPATHY AT THE DIABETES MELLITUS TYPE 1
by: E. B. Balzhinimayev, et al.
Published: (2012-11-01)